
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.16 | 11.1111111111 | 1.44 | 1.79 | 1.26 | 4284440 | 1.46475523 | CS |
4 | -1.43 | -47.1947194719 | 3.03 | 3.78 | 1.26 | 4829774 | 2.35146955 | CS |
12 | -12.18 | -88.388969521 | 13.78 | 15 | 1.26 | 2516360 | 4.03690824 | CS |
26 | -11.42 | -87.7112135177 | 13.02 | 16.1 | 1.26 | 1361260 | 5.78087026 | CS |
52 | -14.03 | -89.7632757518 | 15.63 | 16.52 | 1.26 | 903535 | 7.6117302 | CS |
156 | -7.3 | -82.0224719101 | 8.9 | 36.64 | 1.26 | 800616 | 15.93455517 | CS |
260 | -20.9 | -92.8888888889 | 22.5 | 43.92 | 1.26 | 550764 | 16.68736317 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions